Effect of Circulating Peptide YY on Gallbladder Emptying in Humans

References

• Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci 1989;79:2514–8.
   Web of Science ®Google Scholar
• Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985;89:1070–7.
   Google Scholar
• Aponte GW, Fink AS, Meyer JH, Tatemoto K, Taylor IL. Regional distribution and release of peptide YY with fatty acids of different chain length. Am J Physiol 1985;249:G745–50.
   Google Scholar
• Greeley GH Jr, Jeng YJ, Gomez G, Hashimoto T, Hill FLC, Kern K, et al. Evidence for regulation of peptide-YY release by the proximal gut. Endocrinology 1989;124:1438–43.
   PubMed Web of Science ®Google Scholar
• Pappas TN, Debas HT, Goto Y, Taylor IL. Peptide YY inhibits meal-stimulated pancreatic and gastric secretion. Am J Physiol 1985;248:G118–23.
   PubMed Web of Science ®Google Scholar
• Serrano P, Yago MD, Mañas M, Calpena R, Mataix J, Martínez-Victoria E. Influence of type of dietary fat (olive and sunflower oil) upon gastric acid secretion and release of gastrin, somatostatin, and peptide YY in man. Dig Dis Sci 1997;42:626–33.
   Google Scholar
• Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese- Hamilton AJ, Tatemoto K, et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985;89:494–9.
   Google Scholar
• Hoentjen F, Hopman WPM, Maas MIM, Jansen JBMJ. Role of circulating PYY in the inhibition of gastric acid secretion by dietary fat in humans. Scand J Gastroenterol 2000;35:166–71.
   PubMed Web of Science ®Google Scholar
• Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987;28:166–70.
   Google Scholar
• Mannon P, Taylor IL. The pancreatic polypeptide family. In: Walsh JH, Dockray GJ, editors. Gut peptides: biochemistry and physiology. New York: Raven Press; 1994. p. 341–70.
   Google Scholar
• Niebergall-Roth E, Teyssen S, Singer MV. Neurohormonal control of gallbladder motility. Scand J Gastroenterol 1997;32:737–50.
   PubMed Web of Science ®Google Scholar
• Fisher RS, Rock E, Malmud LS. Gallbladder emptying response to sham feeding in humans. Gastroenterology 1986;90:1854–7.
   Google Scholar
• Hopman WPM, Jansen JBMJ, Rosenbusch G, Lamers CBHW. Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. Digestion 1987;38:197–203.
   PubMed Web of Science ®Google Scholar
• Yamamura T, Takahashi T, Kusunoki M, Kantoh M, Seino Y, Utsunomiya J. Gallbladder dynamics and plasma cholecystokinin responses after meals, oral water, or sham feeding in healthy subjects. J Med Sci 1988;295:102–7.
   Google Scholar
• Cantor P, Mortensen PE, Myhre J, Gjorup I, Worning H, Stahl E, et al. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans. Gastroenterology 1992;102:1742–51.
   PubMed Web of Science ®Google Scholar
• Hildebrand P, Beglinger C, Gyr K, Jansen JBMJ, Rovati LC, Zuercher M, et al. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest 1990;85:640–6.
   PubMed Web of Science ®Google Scholar
• Hopman WPM, Kerstens PJSM, Jansen JBMJ, Rosenbusch G, Lamers CBHW. The effect of graded physiologic doses of cholecystokinin on gallbladder contraction measured by ultrasonography. Gastroenterology 1985;89:1242–7.
   Google Scholar
• Kerstens PJSM, Lamers CBHW, Jansen JBMJ, de Jong AJL, Hessels M, Hafkenscheid JCM. Physiological plasma concentrations of cholecystokinin stimulate pancreatic enzyme secretion and gallbladder contraction in man. Life Sci 1985;36:565–9.
   Google Scholar
• Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, et al. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. J Clin Invest 1989;84:1220–5.
   PubMed Web of Science ®Google Scholar
• Lluis F, Fujimura M, Lonovics J, Guo Y-S, Gomez G, Greeley GH Jr, et al. Peptide YY and gallbladder contraction. Studies in vivo and in vitro. Gastroenterology 1988;94:1441–6.
   PubMed Web of Science ®Google Scholar
• Guo Y-S, Singh P, Gomez G, Greeley GH Jr, Thompson JC. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones. Gastroenterology 1987;92:1202–8.
   Google Scholar
• Pappas TN, Debas HT, Taylor IL. Enterogastrone-like effect of peptide YY is vagally mediated in the dog. J Clin Invest 1986; 77:49–53.
   Google Scholar
• Wettergren A, Petersen H, Ørskov C, Christiansen J, Sheikh SP, Holst JJ. Glucagon-like peptide-1 7–36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 1994;29: 501–5.
   Google Scholar
• Feldman M, Richardson C, Taylor I, Walsh J. Effect of atropine on vagal release of gastrin and pancreatic polypeptide. J Clin Invest 1979;63:294–8.
   PubMed Web of Science ®Google Scholar
• Konturek SJ, Popiela T, Slowiaczek M, Bielanski W. Gastric acid and pancreatic polypeptide responses to modified sham feeding. Effects of truncal and parietal cell vagotomy. Gut 1987;28:280–6.
   PubMed Web of Science ®Google Scholar
• Schwartz TW. Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 1983;85:1411–25.
   PubMed Web of Science ®Google Scholar
• Rozé C, Molis C, Fu-Cheng X, Ropert A, Genève J, Galmiche JP. Peptide YY inhibition of prostaglandin-induced intestinal secretion is haloperidol-sensitive in humans. Gastroenterology 1997;112:1520–8.
   Google Scholar
• Everson GT, Braverman DZ, Johnson ML, Kern F Jr. A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction. Gastroenterology 1980;79:40–6.
   Google Scholar
• Hopman WPM, Brouwer WFM, Rosenbusch G, Jansen JBMJ, Lamers CBHW. A computerized method for rapid quantification of gallbladder volume from real-time sonograms. Radiology 1985;154:236–7.
   Google Scholar
• Jansen JBMJ, Hopman WPM, Lamers CBHW. A decade of experiences with radioimmunoassays for cholecystokinin in The Netherlands. Scand J Gastroenterol 1992;27 Suppl 200:47–54.
   PubMed Web of Science ®Google Scholar
• Jansen JBMJ, Lamers CBHW. Radioimmunoassay of cholecystokinin in human tissue and plasma. Clin Chim Acta 1983;131:305–16.
   PubMed Web of Science ®Google Scholar
• Jansen JBMJ, Lamers CBHW. Molecular forms of cholecysto- kinin in human plasma during infusion of bombesin. Life Sci 1983;33:2197–5.
   PubMed Web of Science ®Google Scholar
• Lamers CBHW, Diemel CM, van Leer E, van Leusen R, Peetoom JJ. Mechanism of elevated serum pancreatic polypeptide concentrations in chronic renal failure. J Clin Endocrinol Metab 1982;55:922–6.
   Google Scholar
• Maas MIM, Hopman WPM, Katan MB, Jansen JBMJ. Release of peptide YY and inhibition of gastric acid secretion by long- chain and medium-chain triglycerides but not by sucrose polyester in men. Eur J Clin Invest 1998;28:123–30.
   PubMed Web of Science ®Google Scholar
• Van Battum PL, Hopman WPM, Salemans JM, Kuijpers JH, Nagengast FM, Jansen JBMJ. Impaired release of peptide YY in patients with proctocolectomy and ileal pouch-anal anastomosis. Scand J Gastroenterol 1999;34:404–8.
   PubMed Web of Science ®Google Scholar
• Hopman WPM, Rosenbusch G, Hectors MPC, Jansen JBMJ. Effect of predigested fat on intestinal stimulation of plasma cholecystokinin and gall bladder motility in coeliac disease. Gut 1995;36:17–21.
   PubMed Web of Science ®Google Scholar
• Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR. Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 1986;90:379–84.
   Google Scholar
• Sjölund K, Ekman R. Increased plasma levels of peptide YY in coeliac disease. Scand J Gastroenterol 1988;23:297–300.
   Google Scholar
• Masclee AAM, Jansen JBMJ, Corstens FHM, Lamers CBHW. Reversible gall bladder dysfunction in severe pancreatic insufficiency. Gut 1989;30:866–72.
   PubMed Web of Science ®Google Scholar
• Maton PN, Selden AC, Fitzpatrick ML, Chadwick VS. Defective gallbladder emptying and cholecystokinin release in celiac disease. Gastroenterology 1985;88:391–6.
   PubMed Web of Science ®Google Scholar
• Lloyd KCK, Grandt D, Aurang K, Eysselein VE, Schimiczek M, Reeve JR Jr. Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors. Am J Physiol 1990;270:G123–7.
   Google Scholar
• Lloyd KCK, Amirmoazzami S, Friedik F, Heynio A, Solomon TE, Walsh JH. Candidate canine enterogastrones: acid inhibition before and after vagotomy. Am J Physiol 1997;272:G1236–42.
   PubMed Web of Science ®Google Scholar